XKRX:002720 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
XKRX:002720 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Kukje Pharma Co's quarterly common stock stayed the same from Dec. 2023 (₩21,160 Mil) to Mar. 2024 (₩21,160 Mil) and stayed the same from Mar. 2024 (₩21,160 Mil) to Jun. 2024 (₩21,160 Mil).
Kukje Pharma Co's annual common stock increased from Dec. 2021 (₩19,276 Mil) to Dec. 2022 (₩20,195 Mil) and increased from Dec. 2022 (₩20,195 Mil) to Dec. 2023 (₩21,160 Mil).
The historical data trend for Kukje Pharma Co's Common Stock can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kukje Pharma Co Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
Common Stock | Get a 7-Day Free Trial | 18,400.52 | 18,400.52 | 19,276.09 | 20,195.15 | 21,159.83 |
Kukje Pharma Co Quarterly Data | ||||||||||||||||||||
Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | |
Common Stock | Get a 7-Day Free Trial | 21,159.83 | 21,159.83 | 21,159.83 | 21,159.83 | 21,159.83 |
Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.
The par value of common stocks is meaningless. It is usually set at an absurdly low number.
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.